These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38977961)

  • 21. Tumour necrosis factor-α promotes BMHSC differentiation by increasing P2X7 receptor in oestrogen-deficient osteoporosis.
    Lu J; Zhou Z; Ma J; Lu N; Lei Z; Du D; Chen A
    J Cell Mol Med; 2020 Dec; 24(24):14316-14324. PubMed ID: 33169524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.
    Zhang Q; Hu S; He Y; Song Z; Shen Y; Zhao Z; Zhang Q; Qin L; Zhang Q
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of bone resorption by Mori Radicis Cortex through NFATc1 and c-Fos signaling-mediated inhibition of osteoclast differentiation.
    Hong S; Cho HR; Kim JH; Kim M; Lee S; Yang K; Lee Y; Sohn Y; Jung HS
    J Chin Med Assoc; 2024 Jun; 87(6):615-626. PubMed ID: 38651853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
    Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
    J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption.
    Sun J; Cai G; Shen J; Cheng P; Zhang J; Jiang D; Xu X; Lu F; Chen L; Chen H
    Drug Des Devel Ther; 2023; 17():1275-1288. PubMed ID: 37138583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR‑21 promotes osteoclastogenesis through activation of PI3K/Akt signaling by targeting Pten in RAW264.7 cells.
    Wang S; Liu Z; Wang J; Ji X; Yao Z; Wang X
    Mol Med Rep; 2020 Mar; 21(3):1125-1132. PubMed ID: 32016444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis.
    Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D
    Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
    Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss.
    Han SY; Kim YK
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Icariin inhibits thioacetamide-induced osteoclast differentiation through RANKL-p38/ERK-NFAT pathway].
    Cheng LY; Jin XL; Chen XW; Chen J; Ren J; Huang H; Xu J
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5882-5889. PubMed ID: 36472007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An LGR4 agonist activates the GSK‑3β pathway to inhibit RANK‑RANKL signaling during osteoclastogenesis in bone marrow‑derived macrophages.
    Jang Y; Lee H; Cho Y; Choi E; Jo S; Sohn HM; Kim BC; Ko YJ; Lim W
    Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 38063193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of moderate intensity static magnetic fields on osteoclastic differentiation in mouse bone marrow cells.
    Kim EC; Park J; Noh G; Park SJ; Noh K; Kwon IK; Ahn SJ
    Bioelectromagnetics; 2018 Jul; 39(5):394-404. PubMed ID: 29709064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Osteoporotic Effects of
    Lim HJ; Park EJ; Won YS; Bak SG; Cheong SH; Lee SW; Lee S; Lee SJ; Rho MC
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of pharmacodynamics and metabolomics reveals the therapeutic effects of 6-acetylacteoside on ovariectomy-induced osteoporosis mice.
    Liu J; Ding S; Yang L; Zhao X; Ren R; Wang Y; Su C; Chen J; Ma X
    Phytomedicine; 2022 Nov; 106():154399. PubMed ID: 36057143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways.
    Liou SF; Hsu JH; Lin IL; Ho ML; Hsu PC; Chen LW; Chen IJ; Yeh JL
    PLoS One; 2013; 8(7):e69468. PubMed ID: 23936022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-κB and MAPK signaling pathways.
    Tang CY; Wang H; Zhang Y; Wang Z; Zhu G; McVicar A; Li YP; Chen W
    Int J Biol Sci; 2022; 18(6):2392-2405. PubMed ID: 35414778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
    Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
    Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.